Fibroblast growth factor 2 mediates isoproterenol-induced cardiac hypertrophy through specific MAPK and PKC pathways

被引：0
|
作者：
House, S [1 ]
El Schultz, J [1 ]
Glascock, B [1 ]
Kimball, T [1 ]
Doetschman, T [1 ]
机构：
[1] Univ Cincinnati, Coll Med, Cincinnati, OH USA
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2004年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [1] Fibroblast growth factor-2 mediates angiotensin II-induced cardiac hypertrophy in hypertensive mice through MAPK activation
    Pellieux, C
    Sauthier, T
    Aubert, JF
    Brunner, HR
    Pedrazzini, T
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S145 - S145
  • [2] AT1 receptor mediates isoproterenol-induced cardiac hypertrophy and oxidative stress
    Tajima, S
    Tsutiya, K
    Ohnishi, H
    Kanematsu, Y
    Yoshizumi, M
    Tamaki, T
    Mason, R
    Takiguti, Y
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 62P - 62P
  • [3] Strain-specific Cardiac Fibroblast Response to Isoproterenol-induced Cardiac Fibrosis
    Park, Shuin
    Ranjbarvaziri, Sara
    Lay, Fides
    Zhao Peng
    Lusis, Aldons J.
    Ardehali, Reza
    [J]. CIRCULATION RESEARCH, 2017, 121
  • [4] L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways
    Lin, Yan
    Wang, Li-Na
    Xi, Yu-Hui
    Li, Hong-Zhu
    Xiao, Feng-Gang
    Zhao, Ya-Jun
    Tian, Ye
    Yang, Bao-Feng
    Xu, Chang-Qing
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 103 (02) : 124 - 130
  • [5] Hydrogen (H2) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
    Zhang, Yaxing
    Xu, Jingting
    Long, Zhiyuan
    Wang, Chen
    Wang, Ling
    Sun, Peng
    Li, Ping
    Wang, Tinghuai
    [J]. FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [6] Paricalcitol improved cardiac hypertrophy and fibrosis through upregulation of fibroblast growth factor-23 and downregulation of transforming growth factor-beta in a rat model of isoproterenol-induced cardiomyopathy
    Wu, Chieh-Jen
    Li, Yu-He
    Chen, Hsin-Hung
    [J]. CHINESE JOURNAL OF PHYSIOLOGY, 2023, 66 (05): : 306 - 312
  • [7] Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways
    Song, Renxing
    Xiong, Chunming
    Bai, Juncai
    Bai, Zhenzhou
    Liu, Wei
    [J]. CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [8] Artemisinin Attenuates Isoproterenol-induced Cardiac Hypertrophy via the ERK1/2 and p38 MAPK Signaling Pathways
    Song, Renxing
    Xiong, Chunming
    Bai, Juncai
    Bai, Zhenzhou
    Liu, Wei
    [J]. CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
  • [9] Overexpression of insulin-like growth factor-I in hearts of rats with isoproterenol-induced cardiac hypertrophy
    Suzuki, J
    Ohno, I
    Nawata, J
    Miura, S
    Ikeda, J
    Shirato, K
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (05) : 635 - 644
  • [10] Fibroblast growth factor-2 mediates angiotensin II-induced cardiac hypertrophy in renovascular hypertension
    Pellieux, C
    Foletti, A
    Sauthier, T
    Aubert, JF
    Beermann, F
    Brunner, HR
    Thierry, P
    [J]. HYPERTENSION, 2000, 36 (04) : 683 - 683
12345